Today's Hours: 8:00am - 6:00pm
Lane Medical Library

Search

Filter Results

Did You Mean:

Search Results

Sort by
relevance
  • Book
    Christopher M. Loftus, editor.
    Contents:
    Part 1. General Principles
    Physiology of Hemostasis
    Laboratory Assessment of Physiologic and Pathologic Hemostasis
    Current Anticoagulation Drugs and Mechanisms of Action
    Reversal of Target-Specific Oral Anticoagulants
    Overview, Treatment, Measurement, and Modification of Platelet Function
    Role of Antiplatelet Therapy in Neurosurgery: Efficacy and Safety Profiles
    Part 2. Coagulation Issues Across all Patient Spectrums
    Congenital Coagulation Disorders
    Acquired Coagulation Disorders
    Regulation and Dysregulation of Fibrinolysis
    Risks Associated with Administration of Allogeneic Blood Components
    Common Coagulation Disorders That May Arise Intraoperatively
    Evaluation and Management of Untoward Intraoperative Bleeding
    Treatment of Disseminated Intravascular Coagulation (DIC)
    Heparin-Induced Thrombocytopenia (HIT)
    Anticoagulation in Cardiovascular Diseases
    Workup and Treatment of Pulmonary Embolus
    Part 3. Coagulation Issues Specific to Neurosurgery
    Classes of Drugs and Blood Products for Acute Reversal of Anticoagulant Effect
    Rescue Strategies to Facilitate Emergency Neurosurgery in Patients on Antiplatelet or Anticoagulant Agents
    Considerations for Coagulation in the Multi-Trauma Patient
    Cerebral Venous Sinus Thrombosis
    Coagulation Studies in Preoperative Neurosurgery Patients
    Safe Strategies for Gradual Suspension and Re-institution of Anticoagulation to Permit Elective Surgery
    Spontaneous Intracerebral Hemorrhage due to Coagulation Disorders
    Prophylactic Screening for Venous Thromboembolism in Neurosurgical Patients
    Venous Thromboembolism Prophylaxis in Neurosurgery
    Can Patients with Known Intracranial and Intraspinal Vascular Lesions be Anticoagulated?
    Intrathecal Access and Devices in Patients on Antiplatelet or Anticoagulant Therapy
    Is it Safe to Shunt Anti-coagulated NPH Patients?
    Surgical Hemostasis in the Era of Anticoagulation: Guidelines and Recommendations Summary.
    Digital Access Springer 2016
  • Article
    Mark J, Ekedahl C, Hagman A.
    Hum Genet. 1977 May 10;36(3):277-82.
    The cytogenetic findings by G-banding in two histiocytic lymphomas are described. Both tumors had a stemline with a 14q+ marker. The origin of the extra segment on No. 14 was determined, and it was different in the two cases. These observations, and those from non-Burkitt lymphomas with 14q+ markers reported in the literature, indicate an inconsistent pattern for the origin of the extra material on No. 14. The only feature in common for all cases is instability of the distal region of the long arm of No. 14, and liability of this region to be involved in structural rearrangements, particularly translocations.
    Digital Access Access Options